INSIGHTS ON QUALITY ASSURANCE

• Where Speed Meets Complexity In Bioprocess Development

  Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.

• A CCS Is A Purpose-Built Machine, Not A Black Box: Understand The Workings

  Learn how to transform your contamination control strategy into a dynamic operational framework that identifies risks and strengthens facility control.

• How Automated NGS Solutions Advance Rare Disease Research

  See how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.

• Site Expansion Success Blueprint

  Discover how a global pharmaceutical manufacturer unified six sites under one asset management strategy, improving compliance and scalability to help teams plan, prepare data, and expand confidently.

• The Shift To GMP-Compliant Automation In CGT Manufacturing

  10/6/2025

  Manual processes are yielding to automated, GMP-compliant closed systems in CGT manufacturing. This shift is crucial for meeting Annex 1 contamination standards and creating scalable, reliable commercial production.

• Choosing 21 CFR Part 11 Software: A Practical Buyer's Guide

  3/23/2026

  Electronic records require audit trails, two-component signatures, authority checks, and ALCOA+ controls. See how to evaluate Part 11 software, build validation packages, and maintain inspection readiness.

• How To Reduce Batch Loss In Biopharma Production

  12/12/2025

  Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.

• Scale-Up Of A Transient rAAV Production Process

  11/3/2025

  Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.

• Human Performance In Pharma: Strengthening The Biotech Workforce

  11/24/2025

  Transforming the pharma workforce requires strategic partnerships and a shift toward behavioral and operational readiness, moving beyond simple technical training to ensure performance and compliance.